GlassScriptPhysician profile
Richard Alan Wilde
NPI 1912923830
$4,331.55
in general payments reported to CMS, 2019-2025
37 companies · $943 in 2025
The $943 reported for 2025 was more than what 97% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $455 · 2020: $264 · 2021: $539 · 2022: $531 · 2023: $712 · 2024: $887 · 2025: $943.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,524 · Long Term Medical Supply Or Device Loan: $18.36.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,524.01 |
| Long Term Medical Supply Or Device Loan | $18.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corium, LLC | $754.76 | 2022-2025 | Azstarys |
| Sanofi-Aventis U.S. LLC | $327.94 | 2023-2025 | |
| Supernus Pharmaceuticals, INC. | $309.71 | 2021-2024 | Qelbree, Qelbree |
| Tris Pharma INC | $279.96 | 2019-2025 | Dyanavel Xr, Onyda Xr |
| Merck Sharp & Dohme LLC | $245.80 | 2019-2025 | Vaxneuvance, Gardasil 9, Vaxelis |
| Kaleo, INC. | $234.36 | 2019-2023 | Auvi-Q |
| Cranial Technologies, INC | $208.14 | 2019-2024 | Doc Band |
| Ironshore Pharmaceuticals INC. | $188.85 | 2019-2024 | Jornay Pm |
| Ars Pharmaceuticals Operations, INC. | $167.63 | 2025 | Neffy |
| Pfizer INC. | $161.33 | 2020-2024 | |
| Phadia US INC. | $149.12 | 2022-2025 | Immunocap |
| Glaxosmithkline, LLC. | $142.93 | 2019-2025 | Bexsero |
| Neos Therapeutics, LP | $137.82 | 2019-2025 | Cotempla Xr-Odt |
| Sobi, INC | $98.90 | 2019-2022 | |
| Ptc Therapeutics, INC. | $95.11 | 2020-2025 | Kebilidi |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| W. L. Gore & Associates, INC. | $86.67 | 2025 | Gore Cardioform Asd Occluder |
| Genentech USA, INC. | $85.25 | 2019-2021 | |
| Alk-Abello, INC | $82.34 | 2021-2025 | Neffy, Grastek, Odactra |
| Astrazeneca Pharmaceuticals LP | $73.87 | 2023-2024 | Flumist Quadrivalent |
| Collegium Pharmaceutical, INC. | $70.51 | 2025 | Jornay Pm |
| Vertical Pharmaceuticals, LLC | $58.91 | 2024-2025 | Relexxii |
| Shire North American Group INC | $39.29 | 2019 | |
| Noven Therapeutics, LLC | $37.39 | 2023-2024 | Xelstrym |
| Qol Medical, LLC | $31.17 | 2019 | |
| Tersera Therapeutics LLC | $27.88 | 2023 | Quzyttir |
| Organon LLC | $25.88 | 2025 | |
| Hologic Sales and Service, LLC | $25.42 | 2023 | Aptima, Third Wave |
| Takeda Pharmaceuticals U.S.A., INC. | $24.90 | 2021 | |
| Verrica Pharmaceuticals INC. | $24.69 | 2025 | Ycanth |
| Aimmune Therapeutics, INC. | $21.25 | 2023 | |
| Baxter Healthcare | $18.36 | 2023 | Hillrom - Cp 150 Resting Electrocardiograph |
| Amneal Pharmaceuticals LLC | $18.12 | 2019 | |
| Abbvie INC. | $17.41 | 2021 | |
| Sarepta Therapeutics, INC. | $17.12 | 2019 | |
| Rhodes Pharmaceuticals L.P. | $15.24 | 2019 | |
| Adlon Therapeutics L.P. | $14.98 | 2020 | |
| Mylan Pharmaceuticals INC. | $12.54 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Richard Wilde listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.